Martin Babler
Director/Board Member at OMEGA ALPHA SPAC
Net worth: - $ as of 30/04/2024
Network origin in Martin Babler first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.
220
| Non-Profit Organization | Miscellaneous Commercial Services | 220 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
200
| Subsidiary | Biotechnology | 200 |
| Public Company | Pharmaceuticals: Major | 92 | |
| Public Company | Pharmaceuticals: Major | 33 | |
| Public Company | Biotechnology | 22 | |
| Subsidiary | Pharmaceuticals: Major | 21 | |
15
| Public Company | Pharmaceuticals: Major | 15 |
| Subsidiary | Pharmaceuticals: Major | 13 | |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021.
9
| Holding Company | Pharmaceuticals: Major | 9 |
| Private Company | Financial Conglomerates | 7 | |
Sardona Therapeutics, Inc.
5
| Private Company | 5 | |
Talima Therapeutics, Inc.
 Talima Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talima Therapeutics, Inc. operated as a drug delivery company. It had developed a micro implant delivery technology for the localized application of small molecule drugs. The firm’s product was in phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the toenails. The company was founded in 2004 and was headquartered in San Carlos, CA.
2
| Extinct | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Martin Babler via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Yale University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Compliance Officer | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal President Public Communications Contact | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact General Counsel | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Human Resources Officer Chief Operating Officer | |
| MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO Chief Executive Officer | |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Investment Managers | Consultant / Advisor Private Equity Investor Founder Private Equity Investor | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Founder Founder | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Investor Relations Contact | |
| IMMUNOGEN, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chief Executive Officer | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| SANOFI | Biotechnology | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Undergraduate Degree Masters Business Admin | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Corporate Officer/Principal Private Equity Investor | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Indiana University | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| TRANSLATE BIO, INC. | Biotechnology | Chairman Founder Director/Board Member | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| Michigan State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
| University of Mumbai | College/University | Graduate Degree Graduate Degree | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| University of Geneva | College/University | Doctorate Degree Doctorate Degree | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member |
Statistics
International
| United States | 46 |
| Switzerland | 3 |
| France | 2 |
| Ireland | 2 |
| India | 2 |
Sectoral
| Health Technology | 34 |
| Consumer Services | 13 |
| Finance | 4 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 874 |
| Independent Dir/Board Member | 266 |
| Corporate Officer/Principal | 262 |
| Chairman | 184 |
| Chief Executive Officer | 161 |
Most connected contacts
| Insiders | |
|---|---|
| James Tananbaum | 60 |
| Jean-Francois Formela | 47 |
| Steven Paul | 38 |
| John Maraganore | 37 |
| Otello Stampacchia | 37 |
| Jon Fyrwald | 35 |
| Ian Clark | 35 |
| Flemming Ørnskov | 34 |
| Kathy LaPorte | 34 |
| Louis Lavigne | 32 |
| Norman Selby | 32 |
| Daniel Lynch | 32 |
| Ted Love | 31 |
| N. Coles | 30 |
| Alan Colowick | 30 |
- Stock Market
- Insiders
- Martin Babler
- Company connections
